Impact and utility of follicular lymphoma GELF criteria in routine care: an Australasian Lymphoma Alliance study
Follicular Lymphoma (FL) treatment initiation is largely determined by tumor burden and symptoms. In the pre-rituximab era, the Group d’Etude des Lymphomes Folliculaires (GELF) developed widely adopted criteria to identify high tumor burden FL patients to harmonize clinical trial populations. The u...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Ferrata Storti Foundation
2024-03-01
|
Series: | Haematologica |
Online Access: | https://haematologica.org/article/view/11497 |